Shaolin Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
Shaolin Capital Management's TDACW Position: Q2 2026 in Review
Shaolin Capital Management reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 43% in Q2 2026, selling an estimated $275K and leaving 367,253 shares worth $523K. The position accounts for 0.03% of the portfolio, ranked #283.
Shaolin Capital Management first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Shaolin Capital Management held 367,253 shares of Translational Development Acquisition Corp Warrants worth $523K as of Q2 2026.
- Shaolin Capital Management sold 274,466 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $275K.
- Translational Development Acquisition Corp Warrants made up 0.03% of Shaolin Capital Management's portfolio in Q2 2026, its #283 holding.
- Shaolin Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.